SBIR/STTR Research Award

Novel Caspase Substrates for Live Cells

Award identifier 9629fe4dffe4b871d130caae3c90908b4336609977e01a0108acdfdd7750ea7bAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$132,199

Program and phase

SBIR · Phase I

Award year

2007

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIOTIUM, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): As both initiators and executioners of apoptosis, caspases serve as important drug targets for many major diseases such as neurological diseases, cardiovascular diseases, cancer, autoimmune diseases and diabetes. To date, apoptosis research highly desires cell permeable and sensitive caspase substrates for detecting caspase activation in live cells and animals. By utilizing Biotium's patented technology, we created a novel class green fluorescent caspse-3 substrate that is capable of detecting caspase activity within individual live cell in real-time, and also effectively monitoring nucleus morphology of apoptotic cells. This bi-functional caspase substrate allows studying heterogeneity of cell population during apoptosis, early detection of apoptotic cells and monitoring cellular apoptotic process kinetically. The overall goal of this Phase I SBIR grant application is develop a far-red fluorescent bi-functional caspase-3 substrate that can be used for multiplex detection together with existing popular fluorescent biomolecules such as FITC, Alexa 488, Rhodamine, Texas-red conjugates for immunostaining. Apoptosis or programmed cell death is a distinct, intrinsic cell death program that occurs in various physiological and pathological situations. Disruptions in this process play important roles in many major diseases such as neurological diseases, cancer, autoimmune diseases, diabetes, and cardiovascular diseases. As both initiators and executioners of apoptosis, caspases serve as important drug targets for these diseases. Among them, caspase-3 has been extensively studied for their important roles in apoptosis and necrosis in many tissues. The development of multi- color cell permeable and sensitive caspase substrates described in this project will allows studying caspase-3 activation in live cells and correlation of caspase-3 activation with other cellular events. They also provide novel tools for directly screening caspase inhibitors or activators in live cells. These novel caspase substrates will greatly facilitate our understanding of apoptosis and its relation to various diseases and the development of future therapeutics for apoptosis related diseases.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.